The Trump administration proposed Medicare insurer payment rates that were lower than analysts expected, triggering a sharp selloff in stocks of UnitedHealth Group, Humana, and CVS Health as investors priced in tighter reimbursements.
Major U.S. health insurers CVS Health, Humana, and UnitedHealth are reducing their Medicare Advantage offerings in 2026 due to decreased government reimbursements and rising healthcare costs, leading to plan cuts across numerous counties and states, affecting hundreds of thousands of beneficiaries.
Humana's shares fell significantly after reports indicated that the criteria for earning Medicare bonus payments are becoming more difficult, potentially impacting the company's revenue from Medicare Advantage plans.
Cigna Group has confirmed it is not pursuing a merger with Humana, despite recent speculation. The company remains focused on acquisitions that align with its strategic and financial goals. Cigna plans to reaffirm its 2024 earnings outlook and expects significant growth in 2025. The company's third-quarter sales increased by 30% year-over-year, driven by strong performance in its Evernorth Health Services division. Cigna's stock rose nearly 8% following the announcement, while Humana's stock fell over 6%.
Health insurers like UnitedHealth and Humana saw their stocks tumble after the Biden Administration announced that final Medicare Advantage rates in 2025 won't change from initial plans in January, with UnitedHealth and Humana being the largest Medicare Advantage players. Other insurers like CVS Health and Cigna also retreated, as the Centers for Medicare and Medicaid Services revealed that private Medicare Advantage rates will increase an average 3.7% in 2025, impacting various players in the market.
Humana, the only Fortune 500 company headquartered in Kentucky, is planning to vacate its iconic 27-story headquarters building in downtown Louisville as part of a cost-cutting move, leaving a significant amount of office space empty. The company, which no longer needs the building due to its embrace of hybrid and remote work, will consolidate its Louisville headquarters into its Waterside-Clocktower campus on the east side of downtown, citing significant cost savings and the modern facilities at the new location. The move raises fresh doubts about the company's long-term commitment to the city, and the future use of the iconic tower remains uncertain.
After nearly four decades, Humana is vacating its downtown Louisville headquarters at 500 Main Street and consolidating into the Waterside and Clocktower Buildings due to employees embracing hybrid work. The complete exit from the current headquarters will occur over the next 18 to 24 months, and the company is working with city agencies to identify potential future occupants for the property.
Humana Tower in downtown Louisville will be vacated over the next 18 to 24 months, with employees being relocated to the renovated Waterside Building and nearby Clocktower Building as the company consolidates its campus footprint. The decision comes as Humana adapts to more flexible work styles and reduced daily office utilization, aiming to improve the on-site experience for its employees. Despite the iconic status of the Tower, the company plans to work with city agencies to identify potential future uses for the property, while remaining a strong anchor for the Downtown Louisville business community.
Humana, the only Fortune 500 company headquartered in Kentucky, is planning to vacate its iconic headquarters building in downtown Louisville and consolidate its employees in the Waterside-Clocktower campus on the east side of downtown. The decision to vacate the Humana Tower comes after the company's significant reduction in its hometown footprint over the last five years. The move is primarily driven by the need for more space, with the company's east side buildings offering 40% more square footage than the tower. Humana has also filed a lawsuit against the firms involved in the tower's construction, citing "latent defects" discovered in 2019. The company expects to realize cost savings by vacating the tower and is working with the city to determine its future use.
CenterWell Senior Primary Care, a part of Humana’s Primary Care Organization, is planning to open new senior care centers in the Baton Rouge and New Orleans areas later this year, as part of an ambitious growth plan to open between 30 and 50 new facilities through 2025. The new facilities are expected to open in late spring or early summer and are part of a growing market for senior care in the region, with Ochsner also recently opening a senior care clinic in Bocage.
Humana's stock has plummeted after reporting a surprise loss in the fourth quarter due to higher usage in its Medicare Advantage business, with costs expected to remain elevated through 2024. The surge in older patients seeking care last year led to higher-than-expected costs, impacting the company's earnings forecast. The Medicare Advantage market is facing significant regulatory changes and increased medical cost trends, affecting companies like Humana and UnitedHealth Group. The industry may see disciplined pricing and slower enrollment growth in the future due to changing demographics.
Humana Inc.'s bleak earnings forecast and withdrawal of 2025 guidance signal a challenging future for private Medicare plans, with rising medical costs expected to impact profitability and potentially lead to increased costs for seniors. The company's shares fell sharply, dragging down the sector, as it anticipates having to raise prices and reduce benefits to maintain profit margins. The outlook reflects broader industry concerns, with other major insurers also facing uncertainties related to escalating medical expenses and regulatory changes.
Humana Inc. announced a significant increase in medical costs, leading to a bleak profit outlook for 2023 and 2024, causing its stock price to plummet. The company abandoned its long-term profit target and slashed its profit expectations. The surge in healthcare costs, particularly from older individuals using medical benefits, has impacted its bottom line. This has also raised speculation about potential acquisition by larger players such as Cigna. The company's setback affects its employees, with potential job losses and reduced bonuses.
On Thursday, IBM's stock rose after beating analysts' fourth-quarter earnings and revenue forecasts, while Lam Research gave an encouraging earnings forecast, causing its stock to rise as well. In contrast, Tesla's stock fell significantly due to disappointing fourth-quarter earnings and a warning of lower sales growth, and Humana's stock also dropped after its earnings forecast fell short of Wall Street expectations.
Tesla, American Airlines, Boeing, and Humana are among the stocks making significant moves midday, with Tesla's shares rising after an analyst upgrade, American Airlines and Boeing experiencing declines, and Humana's stock increasing following a strong earnings report.